Detalles de la búsqueda
1.
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
Oncology
; 97(2): 102-111, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230047
2.
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers.
Gynecol Oncol
; 154(2): 314-322, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31204078
3.
Pembrolizumab for the treatment of non-small-cell lung cancer.
N Engl J Med
; 372(21): 2018-28, 2015 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25891174
4.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26952546
5.
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Lancet Oncol
; 17(3): 299-308, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858122
6.
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors.
J Natl Compr Canc Netw
; 13(10): 1225-31, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26483062
7.
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Nat Med
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871975
8.
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 7: e2300041, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315265
9.
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study.
JCO Precis Oncol
; 7: e2200609, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027810
10.
The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.
Cancer Invest
; 30(8): 571-6, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22812722
11.
Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L858R/ T790M/G796S) in cis.
Lung Cancer
; 164: 52-55, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032819
12.
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663640
13.
Managing the patient with borderline resectable lung cancer.
Oncology (Williston Park)
; 24(3): 234-41, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20394135
14.
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.
Clin Cancer Res
; 26(23): 6196-6203, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887725
15.
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study.
Lancet Respir Med
; 7(4): 347-357, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876831
16.
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
Eur J Cancer
; 109: 154-161, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30731276
17.
Five-Year Overall Survival for Patients With Advanced NonâSmall-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
J Clin Oncol
; 37(28): 2518-2527, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154919
18.
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
J Thorac Oncol
; 14(10): 1794-1806, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228626
19.
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037).
J Clin Oncol
; 36(32): 3223-3230, 2018 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30265610
20.
Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study.
Eur J Cancer
; 101: 201-209, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30077125